Global Point of Care Testing for Infectious Disease Market Research Report 2025(Status and Outlook)

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,800	176 Pages	Bosson Research	January, 2025	BOSS19937281

Best Price Guarantee
Price	from $2,800
Length	176 Pages
Publisher	Bosson Research
Published Date	January, 2025
SKU	BOSS19937281

Table of Contents
Description

Report Overview

Point of Care Testing (POCT) for Infectious Disease refers to diagnostic tests conducted at or near the patient, providing rapid results for infectious diseases such as HIV, influenza, and COVID-19. These tests are typically performed in settings outside of traditional laboratories, such as clinics, hospitals, and community health centers. POCT for Infectious Disease plays a crucial role in enabling timely diagnosis, treatment, and management of infectious diseases, ultimately leading to better patient outcomes and public health.

The market for Point of Care Testing for Infectious Disease is experiencing significant growth driven by several key factors. Firstly, the increasing prevalence of infectious diseases globally, coupled with the ongoing COVID-19 pandemic, has heightened the demand for rapid and accurate diagnostic testing solutions. This has led to a surge in research and development activities focused on developing innovative POCT technologies for infectious diseases. Additionally, the growing emphasis on decentralized healthcare delivery and the need for quick decision-making in clinical settings have further propelled the adoption of POCT for Infectious Disease. Moreover, advancements in technology, such as the development of portable and user-friendly testing devices, have made POCT more accessible and convenient for healthcare providers and patients alike.

In addition to these market drivers, the rising awareness about the importance of early detection and management of infectious diseases is expected to drive the market for Point of Care Testing for Infectious Disease in the coming years. Furthermore, the shift towards personalized medicine and the increasing focus on preventive healthcare are likely to create new opportunities for market growth. However, challenges such as regulatory hurdles, quality control issues, and reimbursement concerns may pose some limitations to market expansion. Overall, the market for POCT for Infectious Disease is poised for continued growth as healthcare systems worldwide recognize the value of rapid and accurate diagnostic testing in improving patient care and public health outcomes.

This report provides a deep insight into the global Point of Care Testing for Infectious Disease market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Point of Care Testing for Infectious Disease Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Point of Care Testing for Infectious Disease market in any manner.

Global Point of Care Testing for Infectious Disease Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Roche

Abbott

LifeScan

Siemens Healthineers

Danaher

Ascensia

BioMerieux

ARKRAY

Sinocare

Wondfo

Yuwell

Runbio

KHB

Market Segmentation (by Type)

Immunological Test

Pathogen Nucleic Acid Test

Market Segmentation (by Application)

Hospital

Clinics

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Point of Care Testing for Infectious Disease Market

Overview of the regional outlook of the Point of Care Testing for Infectious Disease Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Point of Care Testing for Infectious Disease Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

1 Research Methodology and Statistical Scope: 1.1 Market Definition and Statistical Scope of Point of Care Testing for Infectious Disease; 1.2 Key Market Segments; 1.2.1 Point of Care Testing for Infectious Disease Segment by Type; 1.2.2 Point of Care Testing for Infectious Disease Segment by Application; 1.3 Methodology & Sources of Information; 1.3.1 Research Methodology; 1.3.2 Research Process; 1.3.3 Market Breakdown and Data Triangulation; 1.3.4 Base Year; 1.3.5 Report Assumptions & Caveats
2 Point of Care Testing for Infectious Disease Market Overview: 2.1 Global Market Overview; 2.1.1 Global Point of Care Testing for Infectious Disease Market Size (M USD) Estimates and Forecasts (2020-2033); 2.1.2 Global Point of Care Testing for Infectious Disease Sales Estimates and Forecasts (2020-2033); 2.2 Market Segment Executive Summary; 2.3 Global Market Size by Region
3 Point of Care Testing for Infectious Disease Market Competitive Landscape: 3.1 Company Assessment Quadrant; 3.2 Global Point of Care Testing for Infectious Disease Product Life Cycle; 3.3 Global Point of Care Testing for Infectious Disease Sales by Manufacturers (2020-2025); 3.4 Global Point of Care Testing for Infectious Disease Revenue Market Share by Manufacturers (2020-2025); 3.5 Point of Care Testing for Infectious Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3); 3.6 Global Point of Care Testing for Infectious Disease Average Price by Manufacturers (2020-2025); 3.7 Manufacturers Point of Care Testing for Infectious Disease Sales Sites, Area Served, Product Type; 3.8 Point of Care Testing for Infectious Disease Market Competitive Situation and Trends; 3.8.1 Point of Care Testing for Infectious Disease Market Concentration Rate; 3.8.2 Global 5 and 10 Largest Point of Care Testing for Infectious Disease Players Market Share by Revenue; 3.8.3 Mergers & Acquisitions, Expansion
4 Point of Care Testing for Infectious Disease Industry Chain Analysis: 4.1 Point of Care Testing for Infectious Disease Industry Chain Analysis; 4.2 Market Overview of Key Raw Materials; 4.3 Midstream Market Analysis; 4.4 Downstream Customer Analysis
5 The Development and Dynamics of Point of Care Testing for Infectious Disease Market: 5.1 Key Development Trends; 5.2 Driving Factors; 5.3 Market Challenges; 5.4 Market Restraints; 5.5 Industry News; 5.5.1 New Product Developments; 5.5.2 Mergers & Acquisitions; 5.5.3 Expansions; 5.5.4 Collaboration/Supply Contracts; 5.6 PEST Analysis; 5.6.1 Industry Policies Analysis; 5.6.2 Economic Environment Analysis; 5.6.3 Social Environment Analysis; 5.6.4 Technological Environment Analysis; 5.7 Global Point of Care Testing for Infectious Disease Market Porter's Five Forces Analysis; 5.7.1 Global Trade Frictions; 5.7.2 Global Trade Frictions and Their Impacts to Point of Care Testing for Infectious Disease Market; 5.8 ESG Ratings of Leading Companies
6 Point of Care Testing for Infectious Disease Market Segmentation by Type: 6.1 Evaluation Matrix of Segment Market Development Potential (Type); 6.2 Global Point of Care Testing for Infectious Disease Sales Market Share by Type (2020-2025); 6.3 Global Point of Care Testing for Infectious Disease Market Size Market Share by Type (2020-2025); 6.4 Global Point of Care Testing for Infectious Disease Price by Type (2020-2025)
7 Point of Care Testing for Infectious Disease Market Segmentation by Application: 7.1 Evaluation Matrix of Segment Market Development Potential (Application); 7.2 Global Point of Care Testing for Infectious Disease Market Sales by Application (2020-2025); 7.3 Global Point of Care Testing for Infectious Disease Market Size (M USD) by Application (2020-2025); 7.4 Global Point of Care Testing for Infectious Disease Sales Growth Rate by Application (2020-2025)
8 Point of Care Testing for Infectious Disease Market Sales by Region: 8.1 Global Point of Care Testing for Infectious Disease Sales by Region; 8.1.1 Global Point of Care Testing for Infectious Disease Sales by Region; 8.1.2 Global Point of Care Testing for Infectious Disease Sales Market Share by Region; 8.2 Global Point of Care Testing for Infectious Disease Market Size by Region; 8.2.1 Global Point of Care Testing for Infectious Disease Market Size by Region; 8.2.2 Global Point of Care Testing for Infectious Disease Market Size Market Share by Region; 8.3 North America; 8.3.1 North America Point of Care Testing for Infectious Disease Sales by Country; 8.3.2 North America Point of Care Testing for Infectious Disease Market Size by Country; 8.3.3 U.S. Market Overview; 8.3.4 Canada Market Overview; 8.3.5 Mexico Market Overview; 8.4 Europe; 8.4.1 Europe Point of Care Testing for Infectious Disease Sales by Country; 8.4.2 Europe Point of Care Testing for Infectious Disease Market Size by Country; 8.4.3 Germany Market Overview; 8.4.4 France Market Overview; 8.4.5 U.K. Market Overview; 8.4.6 Italy Market Overview; 8.4.7 Spain Market Overview; 8.5 Asia Pacific; 8.5.1 Asia Pacific Point of Care Testing for Infectious Disease Sales by Region; 8.5.2 Asia Pacific Point of Care Testing for Infectious Disease Market Size by Region; 8.5.3 China Market Overview; 8.5.4 Japan Market Overview; 8.5.5 South Korea Market Overview; 8.5.6 India Market Overview; 8.5.7 Southeast Asia Market Overview; 8.6 South America; 8.6.1 South America Point of Care Testing for Infectious Disease Sales by Country; 8.6.2 South America Point of Care Testing for Infectious Disease Market Size by Country; 8.6.3 Brazil Market Overview; 8.6.4 Argentina Market Overview; 8.6.5 Columbia Market Overview; 8.7 Middle East and Africa; 8.7.1 Middle East and Africa Point of Care Testing for Infectious Disease Sales by Region; 8.7.2 Middle East and Africa Point of Care Testing for Infectious Disease Market Size by Region; 8.7.3 Saudi Arabia Market Overview; 8.7.4 UAE Market Overview; 8.7.5 Egypt Market Overview; 8.7.6 Nigeria Market Overview; 8.7.7 South Africa Market Overview
9 Point of Care Testing for Infectious Disease Market Production by Region: 9.1 Global Production of Point of Care Testing for Infectious Disease by Region(2020-2025); 9.2 Global Point of Care Testing for Infectious Disease Revenue Market Share by Region (2020-2025); 9.3 Global Point of Care Testing for Infectious Disease Production, Revenue, Price and Gross Margin (2020-2025); 9.4 North America Point of Care Testing for Infectious Disease Production; 9.4.1 North America Point of Care Testing for Infectious Disease Production Growth Rate (2020-2025); 9.4.2 North America Point of Care Testing for Infectious Disease Production, Revenue, Price and Gross Margin (2020-2025); 9.5 Europe Point of Care Testing for Infectious Disease Production; 9.5.1 Europe Point of Care Testing for Infectious Disease Production Growth Rate (2020-2025); 9.5.2 Europe Point of Care Testing for Infectious Disease Production, Revenue, Price and Gross Margin (2020-2025); 9.6 Japan Point of Care Testing for Infectious Disease Production (2020-2025); 9.6.1 Japan Point of Care Testing for Infectious Disease Production Growth Rate (2020-2025); 9.6.2 Japan Point of Care Testing for Infectious Disease Production, Revenue, Price and Gross Margin (2020-2025); 9.7 China Point of Care Testing for Infectious Disease Production (2020-2025); 9.7.1 China Point of Care Testing for Infectious Disease Production Growth Rate (2020-2025); 9.7.2 China Point of Care Testing for Infectious Disease Production, Revenue, Price and Gross Margin (2020-2025)
10 Key Companies Profile: 10.1 Roche; 10.1.1 Roche Basic Information; 10.1.2 Roche Point of Care Testing for Infectious Disease Product Overview; 10.1.3 Roche Point of Care Testing for Infectious Disease Product Market Performance; 10.1.4 Roche Business Overview; 10.1.5 Roche SWOT Analysis; 10.1.6 Roche Recent Developments; 10.2 Abbott; 10.2.1 Abbott Basic Information; 10.2.2 Abbott Point of Care Testing for Infectious Disease Product Overview; 10.2.3 Abbott Point of Care Testing for Infectious Disease Product Market Performance; 10.2.4 Abbott Business Overview; 10.2.5 Abbott SWOT Analysis; 10.2.6 Abbott Recent Developments; 10.3 LifeScan; 10.3.1 LifeScan Basic Information; 10.3.2 LifeScan Point of Care Testing for Infectious Disease Product Overview; 10.3.3 LifeScan Point of Care Testing for Infectious Disease Product Market Performance; 10.3.4 LifeScan Business Overview; 10.3.5 LifeScan SWOT Analysis; 10.3.6 LifeScan Recent Developments; 10.4 Siemens Healthineers; 10.4.1 Siemens Healthineers Basic Information; 10.4.2 Siemens Healthineers Point of Care Testing for Infectious Disease Product Overview; 10.4.3 Siemens Healthineers Point of Care Testing for Infectious Disease Product Market Performance; 10.4.4 Siemens Healthineers Business Overview; 10.4.5 Siemens Healthineers Recent Developments; 10.5 Danaher; 10.5.1 Danaher Basic Information; 10.5.2 Danaher Point of Care Testing for Infectious Disease Product Overview; 10.5.3 Danaher Point of Care Testing for Infectious Disease Product Market Performance; 10.5.4 Danaher Business Overview; 10.5.5 Danaher Recent Developments; 10.6 Ascensia; 10.6.1 Ascensia Basic Information; 10.6.2 Ascensia Point of Care Testing for Infectious Disease Product Overview; 10.6.3 Ascensia Point of Care Testing for Infectious Disease Product Market Performance; 10.6.4 Ascensia Business Overview; 10.6.5 Ascensia Recent Developments; 10.7 BioMerieux; 10.7.1 BioMerieux Basic Information; 10.7.2 BioMerieux Point of Care Testing for Infectious Disease Product Overview; 10.7.3 BioMerieux Point of Care Testing for Infectious Disease Product Market Performance; 10.7.4 BioMerieux Business Overview; 10.7.5 BioMerieux Recent Developments; 10.8 ARKRAY; 10.8.1 ARKRAY Basic Information; 10.8.2 ARKRAY Point of Care Testing for Infectious Disease Product Overview; 10.8.3 ARKRAY Point of Care Testing for Infectious Disease Product Market Performance; 10.8.4 ARKRAY Business Overview; 10.8.5 ARKRAY Recent Developments; 10.9 Sinocare; 10.9.1 Sinocare Basic Information; 10.9.2 Sinocare Point of Care Testing for Infectious Disease Product Overview; 10.9.3 Sinocare Point of Care Testing for Infectious Disease Product Market Performance; 10.9.4 Sinocare Business Overview; 10.9.5 Sinocare Recent Developments; 10.10 Wondfo; 10.10.1 Wondfo Basic Information; 10.10.2 Wondfo Point of Care Testing for Infectious Disease Product Overview; 10.10.3 Wondfo Point of Care Testing for Infectious Disease Product Market Performance; 10.10.4 Wondfo Business Overview; 10.10.5 Wondfo Recent Developments; 10.11 Yuwell; 10.11.1 Yuwell Basic Information; 10.11.2 Yuwell Point of Care Testing for Infectious Disease Product Overview; 10.11.3 Yuwell Point of Care Testing for Infectious Disease Product Market Performance; 10.11.4 Yuwell Business Overview; 10.11.5 Yuwell Recent Developments; 10.12 Runbio; 10.12.1 Runbio Basic Information; 10.12.2 Runbio Point of Care Testing for Infectious Disease Product Overview; 10.12.3 Runbio Point of Care Testing for Infectious Disease Product Market Performance; 10.12.4 Runbio Business Overview; 10.12.5 Runbio Recent Developments; 10.13 KHB; 10.13.1 KHB Basic Information; 10.13.2 KHB Point of Care Testing for Infectious Disease Product Overview; 10.13.3 KHB Point of Care Testing for Infectious Disease Product Market Performance; 10.13.4 KHB Business Overview; 10.13.5 KHB Recent Developments
11 Point of Care Testing for Infectious Disease Market Forecast by Region: 11.1 Global Point of Care Testing for Infectious Disease Market Size Forecast; 11.2 Global Point of Care Testing for Infectious Disease Market Forecast by Region; 11.2.1 North America Market Size Forecast by Country; 11.2.2 Europe Point of Care Testing for Infectious Disease Market Size Forecast by Country; 11.2.3 Asia Pacific Point of Care Testing for Infectious Disease Market Size Forecast by Region; 11.2.4 South America Point of Care Testing for Infectious Disease Market Size Forecast by Country; 11.2.5 Middle East and Africa Forecasted Sales of Point of Care Testing for Infectious Disease by Country
12 Forecast Market by Type and by Application (2026-2033): 12.1 Global Point of Care Testing for Infectious Disease Market Forecast by Type (2026-2033); 12.1.1 Global Forecasted Sales of Point of Care Testing for Infectious Disease by Type (2026-2033); 12.1.2 Global Point of Care Testing for Infectious Disease Market Size Forecast by Type (2026-2033); 12.1.3 Global Forecasted Price of Point of Care Testing for Infectious Disease by Type (2026-2033); 12.2 Global Point of Care Testing for Infectious Disease Market Forecast by Application (2026-2033); 12.2.1 Global Point of Care Testing for Infectious Disease Sales (K Units) Forecast by Application; 12.2.2 Global Point of Care Testing for Infectious Disease Market Size (M USD) Forecast by Application (2026-2033)
13 Conclusion and Key Findings